Potential New Approaches for Prostate Cancer Management in Resource-Limited Countries in Africa
References
- Bray F, Parkin DM. African Cancer Registry Network: Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncology. 2022; 23: 719–728. DOI: 10.1016/S1470-2045(22)00270-4
- Bosland MC, Nettey OS, Phillips AA, et al. Prevalence of prostate cancer at autopsy in Nigeria- A preliminary report. Prostate. 2021; 81: 553–559. DOI: 10.1002/pros.24133
- Bukirwa P, Wabinga H, Nambooze S, et al. Trends in the incidence of cancer in Kampala, Uganda, 1991 to 2015. International Journal of Cancer. 2021; 148: 2129–2138. DOI: 10.1002/ijc.33373
- Parkin DM, Chingonzoh T, Vuma S, et al. Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period. Cancer Epidemiology, Biomarkers & Prevention. 2021; 30: 867–873. DOI: 10.1158/1055-9965.EPI-20-0669
- Seraphin TP, Joko-Fru WY, Kamaté B, et al. Rising prostate cancer incidence in sub-Saharan Africa: A trend analysis of data from the African Cancer Registry Network. Cancer Epidemiology, Biomarkers & Prevention. 2021; 30: 158–165. DOI: 10.1158/1055-9965.EPI-20-1005
- Albertsen PC. PSA testing, cancer treatment, and prostate cancer mortality reduction: What is the mechanism? Urologic Oncology. 2021 Sep 6; S1078–1439(21): 00369–0.
- Fenton JJ, Weyrich MS, Durbin S, et al. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018; 319: 1914–1931. DOI: 10.1001/jama.2018.3712
- Makau-Barasa LK, Manirakiza A, Carvalho AL, et al. Prostate Cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis. Cancer Control. 2022; 29: 10732748221084932. DOI: 10.1177/10732748221084932
- Ikuerowo SO, Omisanjo OA, Bioku MJ, et al. Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination. Pan African Medical Journal. 2013; 15: 129. DOI: 10.11604/pamj.2013.15.129.2489
- Ogundele SO, Ikuerowo SO. A Survey of the Awareness of Prostate Cancer and its Screening among Men Attending the Outpatient Clinics of a Tertiary Health Center in Lagos, Nigeria. Nigerian Journal of Surgery. 2015; 21: 115–118. DOI: 10.4103/1117-6806.162589
- Asare BY, Ackumey MM. Awareness and knowledge about prostate cancer among male teachers in the Sunyani Municipality, Ghana. African Health Sciences. 2021 Jun; 21(2): 655–662. DOI: 10.4314/ahs.v21i2.22
- Meka IA, Okwor CJ, Arum EJ, et al. Evaluation of prostate-specific antigen testing: An empirical survey of laboratories in Nigerian tertiary care centers. International Journal of Medicine and Health Development. 2022; 27: 233–237. DOI: 10.4103/ijmh.IJMH_8_22
- Oranusi CK, Ugezu AI, Nwofor A. Diagnosis of prostate cancer with needle biopsy: should all cases be biopsied before treatment? Nigerian Journal of Clinical Practice. 2012; 15: 48–50. DOI: 10.4103/1119-3077.94097
- OECD. Africa’s Urbanization Dynamics; 2020.
https://www.oecd.org/development/africa-s-urbanisation-dynamics-2020-b6bccb81-en.htm . - Kaboré FA, Zango B, Kambou T, et al. Prostate cancer disease characteristics at the time of diagnosis and initial treatment offered in a tertiary hospital at Ouagadougou (Burkina Faso). Open Journal of Urology. 2014; 4: 7–12. DOI: 10.4236/oju.2014.41002
- Tolani MA, Khalifa AI, Afolayan AO. Clinicopathological characteristics of benign prostatic hyperplasia and prostate cancer in a University Teaching Hospital in Nigeria. Annals of Tropical Pathology. 2020; 11: 56–60. DOI: 10.4103/atp.atp_18_20
- Seraphin TP, Joko-Fru WY, Hämmerl L. Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 2021; 127: 4221–4232. DOI: 10.1002/cncr.33818
- Amin SM, Jibrin PG, Olah FG, et al. Clinicopathological analysis of prostatic lesions in a tertiary hospital in Nigeria. Annals of Tropical Pathology. 2020; 11: 25–28. DOI: 10.4103/atp.atp_14_19
- Agalliu I, Adebiyi AO, Lounsbury DW, et al. The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria. BMC Public Health. 2015; 15: 425. DOI: 10.1186/s12889-015-1754-x
- Ugwumba FO, Nnabugwu II. Prostate cancer characteristics: A descriptive analysis of clinical features at presentation in the last decade in a black African community. Annals of African Medicine. 2022; 21: 153–157. DOI: 10.4103/aam.aam_101_20
- Khauli R, Ferrigno R, Guimarães G, et al. Treatment of localized and locally advanced, high-risk prostate cancer: A report from the First Prostate Cancer Consensus Conference for Developing Countries. JCO Global Oncology. 2021; 7: 530–537. DOI: 10.1200/GO.20.00421
- Yamoah K, Beecham K, Hegarty SE, et al. Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes. BMC Cancer. 2013; 13: 23. DOI: 10.1186/1471-2407-13-23
- Cassell A, Yunusa B, Jalloh M, et al. A review of localized prostate cancer: an African perspective. World Journal of Oncology. 2019; 10: 162–168. DOI: 10.14740/wjon1221
- Index-Mundi. 2022.
https://www.indexmundi.com/g/r.aspx?v=69 . - Central Intelligence Agency. The CIA World Factbook 2020–2021. New York, NY: Skyhorse Publishing. 2020.
- Adedeji IA, Lawal SA, Aluko-Arowolo S. Prostate cancer knowledge gaps among community stakeholders in rural Nigeria: implications for seeking screening. Cancer Causes Control. 2021; 32: 895–901. DOI: 10.1007/s10552-021-01444-y
- Kyei MY, Klufio GO, Ayamba A, et al. Traditional medicines and alternative practice in the management of prostate diseases in southern Ghana. Ghana Medical Journal. 2017; 51: 128–137. DOI: 10.4314/gmj.v51i3.6
- Mwaka AD, Abbo C, Kinengyere AA. Traditional and Complementary Medicine Use Among Adult Cancer Patients Undergoing Conventional Treatment in Sub-Saharan Africa: A Scoping Review on the Use, Safety and Risks. Cancer Management and Research. 2020; 12: 3699–3712. DOI: 10.2147/CMAR.S251975
- Madersbacher S, Mian C, Maier U, et al. Validation of a 10-minute dipstick test for serum prostate-specific antigen. European Urology. 1996; 30: 446–450. DOI: 10.1159/000474213
- Ashida S, Yamasaki I, Kawada C, et al. Evaluation of a rapid one-step PSA test for primary prostate cancer screening. BMC Urology. 2021; 21: 135. DOI: 10.1186/s12894-021-00903-7
- Heyns CF, Naudé AM, Ahmed G, et al. Serum prostate-specific antigen as surrogate for the histological diagnosis of prostate cancer. South African Medical Journal. 2001; 91: 685–689.
- Heyns CF, Basson J, Van der Merwe A, et al. Clinical (non-histological) diagnosis of advanced prostate cancer: Evaluation of treatment outcome after androgen deprivation therapy. South African Journal of Surgery. 2014; 52: 82–85. DOI: 10.7196/sajs.1689
- Liao KM, Wang YL, Chen CY. Medication utilization evaluation of androgen deprivation therapy for prostate cancer in Taiwan. Medicine (Baltimore). 2020; 99:
e23644 . DOI: 10.1097/MD.0000000000023644 - Magoha GA. Management and survival in advanced prostate cancer in Nairobi. East African Medical Journal. 2000; 77: 260–263. DOI: 10.4314/eamj.v77i5.46630
- Chen XQ, Huang Y, Li X, et al. Efficacy of maximal androgen blockade versus castration alone in the treatment of advanced prostate cancer: a retrospective clinical experience from a Chinese medical centre. Asian Journal of Andrology. 2010; 12: 718–727. DOI: 10.1038/aja.2010.42
- Weiner AB, Cohen JE, DeLancey JO, et al. Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort. Journal of Urology. 2020; 203: 933–939. DOI: 10.1097/JU.0000000000000684
- Orakwe DE, Tijani KH, Jeje EA, et al. Bilateral subcapsular orchiectomy versus bilateral total orchiectomy: Comparison of the quality of life post-orchiectomy. Nigerian Postgraduate Medical Journal. 2018; 25: 43–47. DOI: 10.4103/npmj.npmj_169_17
- Chibuzo INC, Takure AO, Shittu OB, et al. Cosmetic Appeal, HRQoL, and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer. Prostate Cancer. 2021; 2021: 9968570. DOI: 10.1155/2021/9968570
- Berry W, Dakhil S, Modiano M, et al. Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer. Journal of Urology. 2002; 168: 2439–2443. DOI: 10.1016/S0022-5347(05)64163-8
- Kendig CE, Samuel JC, Tyson AF, et al. Cancer Treatment in Malawi: A Disease of Palliation. World Journal of Oncology. 2013; 4: 142–146. DOI: 10.4021/wjon683w
- Cassell A, Yunusa B, Jalloh M, et al. Management of Advanced and Metastatic Prostate Cancer: A Need for a Sub-Saharan Guideline. Journal of Oncology. 2019; 2019: 1785428. DOI: 10.1155/2019/1785428
- Mbugua RG, Karanja S, Oluchina S. Effectiveness of a Community Health Worker-Led Intervention on Knowledge, Perception, and Prostate Cancer Screening among Men in Rural Kenya. Advances in Preventative Medicine. 2022; 2022: 4621446. DOI: 10.1155/2022/4621446
DOI: https://doi.org/10.5334/aogh.3994 | Journal eISSN: 2214-9996
Language: English
Submitted on: Oct 23, 2022
Accepted on: Feb 27, 2023
Published on: Feb 20, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Maarten C. Bosland, Olayiwola B. Shittu, Edet E. Ikpi, Oluyemi Akinloye, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.